LKB1 is an established tumor suppressor and LKB1 inactivating mutations appear to have a significant impact on sporadic non-small cell lung cancer development, since the LKB1 gene is mutated in nearly 30% of the tumor cases examined so far [45]. Here, STK11 is linked to neoplasm.